A Phase 1/2, Open-Label Randomized Study Of Ulocuplumab (Bms-936564) In Combination With Low Dose Cytarabine In Subjects With Newly Diagnosed Acute My
Posted Date: May 15, 2019
- Investigator: Zartash Gul
- Type of Study: Drug
The purpose of this research study is to test the safety and effect of an investigational drug called ulocuplumab (also known as BMS-936564, the study drug) and low dose cytarabine (LDAC) in adults with acute myeloid leukemia (AML). The study drug is a type of human protein that is being tested to s
Criteria:
To Be Eligible To Participate In This Study, Patients Must Have Acute Myeloid Leukemia (Aml).
Keywords:
Ca212-016, Cancer, Leukemia, Phase 1/2
For More Information:
Uc Cancer Center
(513) 584-7698
cancer@uchealth.com